Saltar al contenido
Merck

203629

Sigma-Aldrich

Lithium carbonate

99.997% trace metals basis

Sinónimos:

Carbolithium, Carbonic acid lithium salt

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización


About This Item

Fórmula lineal:
Li2CO3
Número de CAS:
Peso molecular:
73.89
Beilstein/REAXYS Number:
3999191
EC Number:
MDL number:
UNSPSC Code:
12352302
eCl@ss:
38020204
PubChem Substance ID:
NACRES:
NA.23

Quality Level

assay

99.997% trace metals basis

form

powder

impurities

≤35.0 ppm Trace Metal Analysis

mp

618 °C (lit.)

density

2.11 g/mL at 25 °C

application(s)

battery manufacturing

SMILES string

[Li+].[Li+].[O-]C([O-])=O

InChI

1S/CH2O3.2Li/c2-1(3)4;;/h(H2,2,3,4);;/q;2*+1/p-2

InChI key

XGZVUEUWXADBQD-UHFFFAOYSA-L

Gene Information

¿Está buscando productos similares? Visita Guía de comparación de productos

pictograms

Exclamation mark

signalword

Warning

hcodes

Hazard Classifications

Acute Tox. 4 Oral - Eye Irrit. 2

Storage Class

13 - Non Combustible Solids

wgk_germany

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Faceshields, Gloves


Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

¿No ve la versión correcta?

Si necesita una versión concreta, puede buscar un certificado específico por el número de lote.

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

K E Morrison et al.
The Lancet. Neurology, 12(4), 339-345 (2013-03-05)
Lithium has neuroprotective effects in cell and animal models of amyotrophic lateral sclerosis (ALS), and a small pilot study in patients with ALS showed a significant effect of lithium on survival. We aimed to assess whether lithium improves survival in
Robert L Findling et al.
Journal of child and adolescent psychopharmacology, 23(2), 80-90 (2013-03-21)
This study examined the long-term effectiveness of lithium for the treatment of pediatric bipolar disorder within the context of combination mood stabilizer therapy for refractory mania and pharmacological treatment of comorbid psychiatric conditions. Outpatients, ages 7-17 years, meeting American Psychiatric
Andrew A Nierenberg et al.
The American journal of psychiatry, 170(1), 102-110 (2013-01-05)
Lithium salts, once the mainstay of therapy for bipolar disorder, have tolerability issues at a higher dosage that often limit adherence. The authors investigated the comparative effectiveness of more tolerable dosages of lithium as part of optimized personalized treatment (OPT).
Harm-Pieter Spaans et al.
The Journal of clinical psychiatry, 74(11), e1029-e1036 (2013-12-18)
To compare the efficacy and cognitive side effects of high-dose unilateral brief pulse electroconvulsive therapy (ECT) with those of high-dose unilateral ultrabrief pulse ECT in the treatment of major depression. From April 2007 until March 2011, we conducted a prospective
Tom Bschor et al.
Journal of clinical psychopharmacology, 33(1), 38-44 (2013-01-02)
Studies of the 1970s and 1980s showed lithium monotherapy to be an effective treatment of acute unipolar major depressive disorder (MDD) and hence as a potential alternative to monoaminergic antidepressants.The objective was to conduct the first comparison of a lithium

Artículos

Lithium-Ion Battery Performance: Dependence on Material Synthesis and Post‑Treatment Methods

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico